Skip to main content

Table 2 Determination of prognostic clinical factors

From: Integrative analysis of ceRNA network reveals functional lncRNAs associated with independent recurrent prognosis in colon adenocarcinoma

Variables Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Age (years, mean ± SD) 0.989 (0.971–1.006) 1.937E−01 NA NA
Gender (Male/Female) 1.630 (1.030–2.579) 3.521E−02* 1.567 (0.984–2.495) 5.872E−02
Pathologic M (M0/M1/−) 3.498 (2.015–6.072) 2.162E−06* 2.358 (0.870–6.391) 9.165E−02
Pathologic N (N0/N1/N2) 0.909 (0.537–1.540) 7.226E−01 NA NA
Pathologic T (T1/T2/T3/T4) 2.310 (1.484–3.597) 3.167E−04* 1.552 (0.909–2.649) 1.070E−01
Pathologic stage (I/II/III/IV/−) 1.849 (1.423–2.402) 2.874E−06* 1.482 (1.105–1.986) 8.541E−03*
lncRNA RS model (High/Low) 2.925 (1.773–4.825) 1.062E−05* 2.438 (1.443–4.118) 8.610E−04*
Recurrence (Yes/No) NA NA NA NA
Recurrence free survival time (months, mean ± SD) NA NA NA NA
  1. *Statistically significant; RS risk score, HR hazard ratio, CI confidence interval, NA not analyzed